Search

everythinglearnresearchcommunity

for

Search:↓

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Finasteride doesn't affect ovulation in normal women.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

Women with nonclassic 21-hydroxylase deficiency can have successful pregnancies through IVF, with certain factors affecting their chances.

Manage women's cholesterol with diet, exercise, and careful treatment choices, especially during pregnancy, PCOS, and menopause.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Women with PCOS face many health risks, but exercise, a healthy diet, and weight management can help.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Early treatment and weight management are important for teenagers with PCOS to reduce symptoms and long-term health risks.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Acne treatment varies, with topical and systemic therapies effective, and more research needed on treatment order and long-term effects.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

The document suggests using natural remedies like bloodletting and honey for various health issues but lacks scientific evidence for their effectiveness.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

More frequent and severe skin problems are linked to higher daily alcohol consumption.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

The study found that women with PCOS have more and larger ovarian follicles and differences in ovarian structure, but these features alone can't always diagnose PCOS.

Deferasirox effectively reduces iron overload in ß-thalassemia patients but may cause some manageable side effects.

A postmenopausal woman's high testosterone levels and symptoms improved after removing a tumor from her ovary.